tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Gokhale NS Systematic approach to managing vernal keratoconjunctivitis in clinical practice: Severity grading system and a treatment algorithm. 2016 Indian J Ophthalmol pmid:27050351
Rotenstein L et al. Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation. 2016 Bone Marrow Transplant. pmid:27272445
Wen Y et al. Tacrolimus restores podocyte injury and stabilizes the expression of Cabin1 in 5/6 nephrectomized rats. 2016 Ren Fail pmid:26905810
Törlén J et al. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation. 2016 Haematologica pmid:27662016
Martial LC et al. A preliminary study searching for the right dose of tacrolimus in very young (≤4 years) renal transplant patients. 2016 J. Pharm. Pharmacol. pmid:27669677
Chang KT et al. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. 2016 J Microbiol Immunol Infect pmid:25315214
Zeng W et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. 2016 Colloids Surf B Biointerfaces pmid:26820107
Nuki Y et al. Comparison of the therapeutic efficacy and safety between tacrolimus and infliximab for moderate-to-severe ulcerative colitis: a single center experience. 2016 Scand. J. Gastroenterol. pmid:26818468
Joko T et al. Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine. 2016 J Nippon Med Sch pmid:26960587
Malachowski SJ et al. Annular Lichenoid Dermatitis of Youth: A Chronic Case Managed Using Pimecrolimus. 2016 Pediatr Dermatol pmid:27653808
Sawada T et al. Experimental Studies on Protective Effects of FK506 Against Hepatic Ischemia-Reperfusion Injury. 2016 J. Med. Invest. pmid:27644569
Chen CA et al. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature. 2016 J Microbiol Immunol Infect pmid:26748735
Yoshida T et al. Oral tacrolimus oil formulations for enhanced lymphatic delivery and efficient inhibition of T-cell's interleukin-2 production. 2016 Eur J Pharm Biopharm pmid:26748381
Radziejewski K and Balicki I Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca. 2016 Acta Vet. Hung. pmid:27653428
Kannegieter NM et al. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:26606072
Wang Z et al. Nanocomposite microparticles (nCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. 2016 Int J Pharm pmid:27568494
Rahnama-Moghadam S et al. Vesicular eruption in a 2-year-old boy. 2016 J Fam Pract pmid:27565104
Lee C et al. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. 2016 Biomed. Pharmacother. pmid:26898446
Cassuto E et al. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. 2016 Transplantation pmid:27653227
Zegarska J et al. Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. 2016 Transplant. Proc. pmid:27496443
Bargnoux AS et al. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method. 2016 Ther Drug Monit pmid:27494947
Zmonarski SC et al. Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. 2016 Transplant. Proc. pmid:27496439
Ashizuka S et al. Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series. 2016 Dig. Dis. Sci. pmid:26470867
Matsui K et al. Betamethasone, but Not Tacrolimus, Suppresses the Development of Th2 Cells Mediated by Langerhans Cell-Like Dendritic Cells. 2016 Biol. Pharm. Bull. pmid:27374298
Kimsa M et al. Transforming growth factor β-related genes in human retinal pigment epithelial cells after tacrolimus treatment. 2016 Pharmacol Rep pmid:27372923
García-Delgado R et al. Systemic Absorption of Topical Tacrolimus in Metastatic Crohn Disease With Skin Ulcers. 2016 Actas Dermosifiliogr pmid:27372545
Vignali D et al. IL-7 Mediated Homeostatic Expansion of Human CD4+CD25+FOXP3+ Regulatory T Cells After Depletion With Anti-CD25 Monoclonal Antibody. 2016 Transplantation pmid:27306531
Saitman A et al. Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay. 2016 Ther Drug Monit pmid:26473523
Tanzi MG et al. Pharmacokinetics of prolonged-release tacrolimus and implications for use in solid organ transplant recipients. 2016 Clin Transplant pmid:27220013
Yamashita T et al. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. 2016 Cancer Chemother. Pharmacol. pmid:27217047
Tremblay S et al. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes. 2016 Prog Transplant pmid:27207408
Emoto C et al. Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients. 2016 Ther Drug Monit pmid:27310200
Badri PS et al. Pharmacokinetics of Tacrolimus and Cyclosporine in Liver Transplant Recipients Receiving 3 Direct-Acting Antivirals as Treatment for Hepatitis C Infection. 2016 Ther Drug Monit pmid:27310199
Rodríguez-Ausín P et al. Topical tacrolimus 0.03% for the treatment of ocular psoriasis. 2016 Arch Soc Esp Oftalmol pmid:27130870
Stifft F et al. Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:27128604
Pirmez R et al. Acne keloidalis nuchae in renal transplant patients receiving tacrolimus and sirolimus. 2016 Australas. J. Dermatol. pmid:27124649
Khaled SK et al. Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. 2016 Biol. Blood Marrow Transplant. pmid:26325438
Lee DR et al. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system. 2016 Int J Nanomedicine pmid:27051286
Cai SC et al. Topical calcineurin inhibitors in eczema and cancer association: A cohort study. 2016 J Dermatolog Treat pmid:27049893
Traitanon O et al. Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. 2015 PLoS ONE pmid:26087255
Wang X et al. Tacrolimus 0.03% ointment in labial discoid lupus erythematosus: A randomized, controlled clinical trial. 2015 J Clin Pharmacol pmid:25951426
Størset E et al. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study. 2015 Transplantation pmid:25886918
Soylu H et al. Survival of renal transplant patients: data from a tertiary care center in Turkey. 2015 Transplant. Proc. pmid:25769571
Ohe M and Bohgaki T A Case of Adult-Onset Still's Disease Treated with Monitoring of Serum Tacrolimus Levels. 2015 Bull Hosp Jt Dis (2013) pmid:26535602
Abdel-Azim H et al. Unrelated donor hematopoietic stem cell transplantation for the treatment of non-malignant genetic diseases: An alemtuzumab based regimen is associated with cure of clinical disease; earlier clearance of alemtuzumab may be associated with graft rejection. 2015 Am. J. Hematol. pmid:26242764
Liu X et al. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy. 2015 Drug Metab. Dispos. pmid:25587129
Roche NA et al. Long-Term Multifunctional Outcome and Risks of Face Vascularized Composite Allotransplantation. 2015 J Craniofac Surg pmid:26468783
Ogul H et al. Severe toxic leukoencephalopathy associated with tacrolimus after living donor liver transplantation. 2015 Acta Neurol Belg pmid:24854146
Krystel-Whittemore M et al. Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis. 2015 BMJ Case Rep pmid:26318171
Vives R et al. Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial. 2015 Clin Ther pmid:26163200